A literature search was carried out for this briefing in accordance with the published process and methods statement. This briefing includes the most relevant and best publicly available evidence ...
Several studies show that the use of percutaneous ventricular assist devices (PVADs), including Impella, is particularly cost-effective in cases of cardiogenic shock: Several studies, including ...
The effects of temporary mechanical circulatory support with a microaxial flow pump on mortality among patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock ...
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the United States Food and Drug Administration (FDA) has approved the company's investigational device exemption application to start ...
Routine use of the Impella CP microaxial flow pump did not improve outcomes and may have contributed to deaths among patients undergoing high-risk percutaneous coronary intervention (PCI), according ...
Medical Device Network on MSN
Abiomed’s Impella heart pump introducer kits linked to leakage issue in FDA alert
Abiomed has reported eight instances of major bleeding, with three ‘contested’ patient deaths related to a leakage issue with ...
PHILADELPHIA, PA—Two large observational studies are casting doubt on how well newer forms of mechanical circulatory support (MCS) are performing in real-world practice in the United States. The ...
PARIS, France—For stabilized patients undergoing complex PCI, left ventricular unloading with an Impella CP microaxial flow pump (Abiomed/Johnson & Johnson MedTech) reduced the need for inotropes but ...
Abiomed has issued an urgent medical device correction for its Impella RP and Impella RP Flex series of heart pumps. In a letter sent to customers on January 27, Abiomed said the voluntary device ...
The Impella heart pump is a small pump that a healthcare professional can insert without surgery. It can help maintain blood flow in people who have CAD, are recovering from cardiogenic shock, or are ...
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ:ABMD) has achieved CE Mark for Impella Connect, the first-of-its kind cloud-based technology that enables secure, real-time, remote viewing of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results